Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 7/20 | 0.43 |
| ▸ | SETDB1 | Q15047 | 2/20 | 0.43 |
| ▸ | BRD9 | Q9H8M2 | 4/20 | 0.43 |
| ▸ | BRD1 | O95696 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.43 |
| ▸ | BPTF | Q12830 | 1/20 | 0.43 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.43 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.43 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.43 |
| ▸ | BRPF3 | Q9ULD4 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 4/20 | 0.40 |
| ▸ | CRBN | Q96SW2 | 6/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30830708 | 0.93 | KAT2B (0.53) | KAT2BSETDB1BRD9BRD1ACHE | |
| SCHEMBL30830589 | 0.93 | KAT2B (0.53) | KAT2BSETDB1BRD9BRD1ACHE | |
| SCHEMBL30830920 | 0.85 | KAT2B (0.42) | KAT2BSETDB1BRD9EGFRCRBN | |
| SCHEMBL30830642 | 0.84 | PLK4 (0.46) | KAT2BBRD9BRD1ACHEBRPF1 | |
| SCHEMBL30830537 | 0.83 | KAT2B (0.38) | KAT2BSETDB1BRD9BRD1ACHE | |
| SCHEMBL30831083 | 0.82 | KAT2B (0.49) | KAT2BBRD9BRD1ACHEBRPF1 | |
| SCHEMBL30830885 | 0.81 | KAT2B (0.55) | KAT2BBRD9BRD1ACHEBRPF1 | |
| SCHEMBL30830478 | 0.81 | KAT2B (0.54) | KAT2BBRD9BRD1ACHEBRPF1 | |
| SCHEMBL30830983 | 0.81 | KAT2B (0.55) | KAT2BBRD9BRD1ACHEBRPF1 | |
| SCHEMBL30830896 | 0.79 | KAT2B (0.58) | KAT2BSETDB1BRD9BRD1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581025-A1 | PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | Auron Therapeutics, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024050078-A1 | PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | AURON THERAPEUTICS, INC. (US) | 2024-03-07 | — | — | WO | disclosed |